Jim McDermott from AstraZeneca: AstraZeneca Presents Full Slate of Studies at ADA

Video

With more than 60 presentations at the American Diabetes Association's meeting AstraZeneca showed a wide range of studies all geared towards helping patients with this condition.

With more than 60 presentations at the American Diabetes Association's meeting AstraZeneca showed a wide range of studies all geared towards helping patients with this condition.

Jim McDermott, US Medical Lead for diabetes at AstraZeneca discussed some of the highlights from these presentations during the New Orleans meeting. McDermott cited several of the medications the company has in the field as well as work being done to improve care in the future as well.

Related Videos
HCPLive Five at APA 2024 | Image Credit: HCPLive
John M. Oldham, MD: A History of Personality Disorder Pathology
Franklin King, MD: Psychedelic Therapy History, Advances, and Hurdles
Robert Weinrieb, MD: Psychiatry-Hepatology Approach for Alcohol-Related Liver Disease
© 2024 MJH Life Sciences

All rights reserved.